期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
1
作者 kadja luana chagas monteiro Marcone Gomes dos Santos Alcântara +1 位作者 Thiago Mendonça de Aquino Edeildo Ferreira da Silva-Júnior 《Neural Regeneration Research》 SCIE CAS CSCD 2021年第5期990-991,共2页
Alzheimer’s disease(AD)is a chronic neurodegenerative disease,which is difficult to diagnose in its early stages.It is associated with aging and consists of a decline in cognitive functions,memory,and other mental ac... Alzheimer’s disease(AD)is a chronic neurodegenerative disease,which is difficult to diagnose in its early stages.It is associated with aging and consists of a decline in cognitive functions,memory,and other mental activities.Some pathophysiological markers are associated with AD progression and worsening,such as the deposition and intracellular accumulation of senile plaques containing amyloid-β(Aβ)peptides,and tau protein hyperphosphorylation,leading to the formation of neurofibrillary tangles. 展开更多
关键词 ALZHEIMER TAU
下载PDF
Electrochemical Evaluation of Aminoguanidine Hydrazone Derivative with Potential Anticancer Activity:Studies of Glassy Carbon/CNT and Gold Electrodes Both Modified with PAMAM
2
作者 Marilya Palmeira Galdino da Silva Ygor Mendes de Oliveira +5 位作者 Anna Caroline Lima Candido Joao Xavier de Araujo-Junior Erica Erlanny da Silva Rodrigues kadja luana chagas monteiro Thiago Mendonca de Aquino Fabiane Caxico de Abreu 《Journal of Biomaterials and Nanobiotechnology》 2020年第1期33-48,共16页
Aminoguanidine hydrazones (AGHs) are a class of compounds that have interesting pharmacological activities. They are derived from the same chemical group as aminoguanidine, so it has mixed properties (receptor and don... Aminoguanidine hydrazones (AGHs) are a class of compounds that have interesting pharmacological activities. They are derived from the same chemical group as aminoguanidine, so it has mixed properties (receptor and donor) in the formation of hydrogen bonds. Its anticancer agent properties were recently highlighted, but the molecules of this class have solubility in aqueous solutions that can be considered low. The identification of this class, by a simple, sensitive and low-cost technique, such as electrochemistry, which also allows the evaluation of its solubilization process through agents such as PAMAM dendrimer is the main objective of the work described here. The electrochemical response of the LQM10 (AGH derivative) was evaluated, as well as its behavior in different electrochemical sensors. Electrochemical experiments were performed in buffered (phosphate at pH 7.02 and acetate at 4.5). LQM10 has a reversible oxidation peak with a potential of +0.22 V. It was efficiently detected in different electrodes tested (glass carbon/CNT, glass carbon/CNT/PAMAM), which proves the viability of the electrodes for various analyses and has the determination of the apparent constant association, indicating its interaction with the analysis that is higher in the presence of the PAMAM encapsulating agent. This was corroborated by the results for the modified gold electrode with MUA and PAMAM. The sum of the results shows the possibility of electrochemically evaluating the Aminoguanidine hydrazone derivative, the viability of electrodes employed and the greater solubilization of LQM10 in the presence of the PAMAM dendrimer. 展开更多
关键词 Drug Delivery Aminoguanidine Hydrazone Modified Electrode PAMAM
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部